1. Anti-Myelin Oligodendrocyte Glycoprotein (MOG) in a Patient with Optic Neuritis
- Author
-
Jette L. Frederiksen, Mathias Falck Schmidt, and Gorm Pihl-Jensen
- Subjects
Pathology ,medicine.medical_specialty ,Neuromyelitis optica ,biology ,business.industry ,Multiple sclerosis ,medicine.disease ,eye diseases ,nervous system diseases ,Myelin oligodendrocyte glycoprotein ,nervous system ,immune system diseases ,Acute disseminated encephalomyelitis ,biology.protein ,medicine ,Optic neuritis ,business ,Encephalitis ,Bilateral optic neuritis - Abstract
The MOG-antibodies (Abs) are detected in variable proportions of patients with different diseases such as Multiple Sclerosis (MS), Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorder, bilateral optic neuritis, acute disseminated encephalomyelitis and anti-NMDA-receptor-antibody-associated encephalitis. The role of MOG-Abs in the clinical setting is unclear.
- Published
- 2018
- Full Text
- View/download PDF